First Wave BioPharma, Inc. Profile Avatar - Palmy Investing

First Wave BioPharma, Inc.

First Wave BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its product candidates include niclosamid…

Biotechnology
US, Boca Raton [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of FWBI's Analysis
CIK: - CUSIP: 33749P101 LEI: - UEI: -
Secondary Listings
FWBI has no secondary listings inside our databases.